Medications Used to Treat Rheumatoid Arthritis

Drug

Some Side Effects

Comments

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Many others

Upset stomach

Stomach ulcers and bleeding

Increased blood pressure

Kidney problems

Possible increased risk of heart attack and stroke

Possible increased risk of bruising and bleeding

NSAIDs treat some symptoms and decrease inflammation but do not prevent damage or alter the course of the disease. They are used less frequently now than in the past.

These drugs are taken by mouth. Some NSAIDs are in cream form and can be applied to the skin directly over painful joints.

Kidney problems

Increased blood pressure

Slightly less risk of stomach ulcer and bleeding than with other NSAIDs

Possible increased risk of heart attack and stroke

Disease-modifying antirheumatic drugs (DMARDs)

Usually mild dermatitis (rash) and skin discoloration

Muscle aches or weakness

Rarely, cardiomyopathy

Eye problems

All DMARDs can slow progression of joint damage as well as gradually decrease pain and swelling.

These drugs are taken by mouth.

Rashes

Liver disease

Damage to nerves (neuropathy)

Diarrhea

Hair loss

Birth defects

Liver disease

Lung inflammation

Nausea

Neutropenia*

Mouth sores

Decreased sperm numbers and fertility in men

Hair loss

Birth defects and increased risk of miscarriage

Stomach problems

Neutropenia* (usually only when treatment begins)

Breakdown of red blood cells (hemolysis)

Liver problems

Rashes

Corticosteroids

Numerous side effects throughout the body with long-term use:

They may not be useful long term because of side effects.

These drugs are usually taken by mouth but can be injected into a muscle (intramuscularly) or a vein (intravenously).

Rarely infection at the injection sites or within the joint

Weakening of tissues if injections are given too frequently for too long

Rarely, bleeding into the joint after injection, particularly in people taking anticoagulants (blood thinners)

These drugs are given by injection into a joint.

Biologic agents

Potential risk of reactivation of infection (particularly tuberculosis and fungal infections)

Skin cancers other than melanoma

Reactivation of hepatitis B

Occasionally systemic lupus erythematosus

Demyelinating neurologic disorders (such as Guillain-Barré syndrome or multiple sclerosis)

These drugs are tumor necrosis factor (TNF) inhibitors.

These drugs produce a dramatic, prompt response in most people.

They can slow joint damage.

Lung problems

Increased susceptibility to infection

Headache

Upper respiratory infection

Sore throat

Nausea

It may be given by vein (intravenously) or by injection under the skin (subcutaneously).

Pain, redness, and itching at injection site

Increased risk of infection

Neutropenia*

It is given by injection under the skin (subcutaneously).

When the drug is being given:

  • Itching at injection site

  • Rashes

  • Back pain

  • High or low blood pressure

  • Fever

After the drug is given:

  • Slightly increased risk of certain infections and possibly cancer

  • Neutropenia*

  • Reactivation of hepatitis B

It is given by vein (intravenously).

Neutropenia* (too few infection-fighting white blood cells)

Suppression of platelet production in the bone marrow, sometimes with increased susceptibility to bleeding

Increase of liver enzymes

Infection (such as tuberculosis) may be serious or lead to sepsis

Neutropenia*

Possibly suppression of platelet production in the bone marrow, sometimes with increased susceptibility to bleeding

Anaphylaxis

Increase of liver enzymes

Rarely perforation of the intestine

It may be given by vein (intravenously) or by injection under the skin (subcutaneously).

Janus kinase (JAK) inhibitors

Risk of infection, particularly reactivation of chickenpox and shingles

Nonmelanoma skin cancer

High cholesterol levels (hypercholesterolemia)

Major cardiovascular events (for example, heart attack, stroke)

Lung cancer

It is taken by mouth.

Risk of infection, particularly reactivation of chickenpox and shingles

Nonmelanoma skin cancer

High cholesterol levels (hypercholesterolemia)

Deep vein thrombosis (DVT)

Major cardiovascular events (for example, heart attack, stroke)

Lung cancer

Risk of infection, particularly reactivation of chickenpox and shingles

Nonmelanoma skin cancer

High cholesterol levels (hypercholesterolemia)

Venous thromboembolism

Major cardiovascular events (for example, heart attack, stroke)

Lung cancer

It is taken by mouth.

* Suppression of blood cell production in the bone marrow can lead to decreased numbers of infection-fighting white blood cells called neutrophils, increasing susceptibility to infection.